HAS vs MNPR · P/E 25, rev $4.75B vs $431.4M cap
Hasbro Inc (HAS) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Hasbro Inc (HAS) is a leisure company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
HAS currently screens at market cap $10.75B and trailing P/E 25.3. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the HAS and MNPR stock pages for the full models.
Not investment advice.